Baylin, S.B., and Herman, J.G. (2000). DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168–174.
Belinsky, S.A. (2004). Gene-promoter hypermethylation as a biomarker in lung cancer. Nat. Rev. Cancer 4, 1–11.
Cretu, A., Sha, X., Tront, J., Hoffman, B., and Liebermann, D.A. (2009). Stress sensor Gadd45 genes as therapeutics targets in cancer. Cancer Ther. 7, 268–276.
Guillouf, C., Grana, X., Selvakumaran, M., Hoffman, B., Giordano, A., and Liebermann, D.A. (1995). Dissection of the genetic programs of p53 G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest. Blood 85, 2691–2698.
Hoffman, B., and Liebermann, D.A. (2008). Gadd45 in stress signaling. J. Mol. Signal. 3, 15.
Hollander, M.C., Sheikh, M.S., Bulavin, D.V., Lundgren, K., Augeri-Henmueller, L., Shehee, R., Molinaro, T.A., Kim, K.E., Tolosa, E., Ashwell, J.D. et al. (1999). Genomic instability in Gadd45adeficient mice. Nat. Genet. 23, 176–184.
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., and Thun, M.J. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58, 71–96.
Jones, P.A., and Baylin, S.B. (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415–428.
Kim, D.S., Kim, M.J., Lee, J.Y., Lee, S.M., Choi, J.E., Lee, S.Y., and Park, J.Y. (2009). Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features. Lung Cancer 65, 247–250.
Qui, W., Zhou, B., Zou, H., Liu, X., Chu, P.G., Lopez, R., Shih, J., Chung, C., and Yen, Y. (2004). Hyperemthylation of growth arrest and DNA damage-inducible gene 45 promoter in human hepatocellular carcinoma. Am. J. Pathol. 165, 1689–1699.
Safar, A.M., Spencer, H. 3rd, Su, X., Coffey, M., Cooney, C.A., Ratnasinghe, L.D., Hutchins, L.F., and Fan, C.Y. (2005). Methylation profiling of archived non-small cell lung cancer: a promising prognostic system. Clin. Cancer Res. 11, 4400–4405.
Schulz, W.A., Alexa, A., Jung, V., Hader, C., Hoffmann, M.J., Yamanaka, M., Fritzsche, S., Wlazlinski, A., Muller, M., Lengauer, T., et al. (2007). Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer. Mol. Cancer 6, 14.
Shaulian, E., and Karin, M. (1999) Stress-induced JNK activation is independent of Gadd45 induction. J. Biol. Chem. 274, 29595–29598.
Sidransky, D. (2002). Emerging molecular markers of cancer. Nat. Rev. Cancer 2, 210–219.
Tront, J.S., Hoffman, B., and Liebermann, D.A. (2006). Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of JNK and p38 stress signaling resulting in apoptosis and senescence. Cancer Res. 66, 8448–8854.
Tsou, J.A., Hagen, J.A., Carpenter, C.L., and Laird-Offringa, I.A. (2002). DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 21, 5450–5461.
Ying, J., Srivastava, G., Hsieh, W.S., Gao, Z., Murray, P., Liao, S.K., Ambinder, R., and Tao, Q. (2005). The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin. Cancer Res. 11, 6442–6449.
Yoo, J., Ghiassi, M., Jirmanova, L., Balliet, A.G., Hoffman, B., Fornace, A.J. Jr, Liebernann, D.A., Bottinger, E.P., and Roberts, A.B. (2003). TGF-β-induced apoptosis is mediated by Smad-dependent expression of GADD45B through p38 activation. J. Biol. Chem. 278, 43001–43007.
Zhang, W., Bae, I., Krishnaraju, K., Azam, N., Fan, W., Smith, K., Hoffman, B., and Liebernann, D.A. (1999). CR6: a third member in the MyD118 and Gadd 45 gene family which functions in negative growth control. Oncogene 18, 4899–4907.